Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

CIR Proposes Prioritizing Triclosan For Review In 2018

Apr 19 2017

• By Lauren Nardella

Related Content

ACI Has $10M Plan For Supporting Antibac Ingredients, If FDA Hasn’t Already Closed The Door

Oct 27 2016

FDA: ‘Vast Majority’ Of Antibac Soaps Need Reformulation Under Final Rule

Sep 02 2016

CIR Panel Prioritizes Paraben Review To Signal EU Before It's 'Too Late'

Apr 11 2016

CIR Considers Another Look At MI Safety In Light Of European Situation

Sep 17 2015

CIR Affirms Triclosan Safety, Opts For Formaldehyde Re-Review

Dec 20 2010

CIR Moves To Reopen Retinol Assessment To Examine New Data

Sep 17 2012

Additional Topics

United States Cosmetics Ingredients Safety Consumer

More from Ingredients & Safety

More from HBW Insight

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window